Invesco DB Agriculture Fund vs Medpace Holdings Inc — how do they compare? Invesco DB Agriculture Fund trades at $27.76, while Medpace Holdings Inc trades at $600.56 (market cap $16.90B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Invesco DB Agriculture Fund nearer its low. Which is the better fit depends on your goals.
| DBA | MEDP | |
|---|---|---|
52-Week High | $28.73 | $620.59 |
52-Week Low | $25.44 | $393.42 |
Market Cap | — | $16.90B |
Sector | — | Technology |
Enterprise Value | — | $16.52B |
Signals from Pluang's Aura AI — not financial advice
DBA trades at $27.69, down 0.47% today, but maintains a strong technical bullish signal with moving averages indicating positive momentum. The fund has outperformed the S&P 500 recently, gaining 5% in July 2026, driven by strength in agricultural commodities. It consolidates near highs with a bullish trend established since 2020, supported by a 3.25% yield.
The outlook remains positive given favorable agricultural market dynamics and geopolitical factors supporting commodity prices. Key risks include sector volatility, management fees, and sensitivity to global crop conditions and trade policies. The fund offers diversified exposure to agricultural futures as a hedge against inflation and supply disruptions.
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
Trailing returns across standard periods
Latest headlines on both assets
The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →